ODDB.org: Open Drug Database

Home - 65731

Swissmedic Registration	65731	Date of registration	07.04.2016
Company name	GlaxoSmithKline AG	Revision date
		Valid until	30.06.2025
Indication		Date of market entry
Index Therapeuticus (BSV)	03.04.50.	Revocation Date	07.08.2025
Index Therapeuticus (Swissmedic)	03.04.50.	Information for professionals	IP

Seq.-No.	Product	Description	Galenic form	ATC-classification
01	Nucala 100 mg	Lyophilisat zur Herstellung einer Injektionslösung	Lyophilisate (Mepolizumabum 100 mg)	R03DX09

2025	©ywesee GmbH